By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS








Company News
Philogen S.p.A. Enters Into Multi-Target Research Agreement With Boehringer Ingelheim In The Field Of DNA-Encoded Chemistry 7/20/2017 7:34:54 AM
The Quest of the Ambitious New Generation of Family-Run Boehringer Ingelheim 7/17/2017 6:56:41 AM
Boehringer Ingelheim Release: Final Phase III Study Results Confirm Benefit Of Praxbind As Reversal Agent For Pradaxa Patients In Emergency Situations 7/11/2017 6:49:25 AM
Boehringer Ingelheim Release: Final Phase III Study Results Reinforces Safety And Efficacy Of Praxbind As Reversal Agent For Pradaxa Patients In Emergency Situations 7/11/2017 6:38:43 AM
Bay Area's Kindred Bio (KIN) Scoops Up Boehringer Ingelheim's Former Space in Kansas 6/26/2017 5:51:17 AM
Boehringer Ingelheim Release: New Data Reveal High Rates Of Stroke History In Asymptomatic Atrial Fibrillation Patients 6/21/2017 6:38:35 AM
Boehringer Ingelheim Presents Phase III Results Demonstrating Clinical Equivalence Of Adalimumab Biosimilar Candidate To HUMIRA 6/14/2017 8:33:01 AM
Boehringer Ingelheim And Eli Lilly (LLY) Diabetes Alliance To Present 33 Abstracts At The American Diabetes Association’s 77th Scientific Sessions 6/6/2017 3:38:18 PM
Boehringer Ingelheim And Lilly Diabetes Alliance To Present 33 Abstracts At The American Diabetes Association’s 77th Scientific Sessions 6/6/2017 12:54:22 PM
Novatek International Selected As Partner For Automation Of Boehringer Ingelheim's Global Environmental Monitoring Program 6/6/2017 10:48:18 AM
12345678910...
//-->